Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?-Reference-Cited by-同舟云学术

Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?

Published:2022-10-03 Issue:6 Volume:35 Page:568-574
ISSN:0951-7375
Container-title:Current Opinion in Infectious Diseases
language:en
Short-container-title:

Author:

Bassetti Matteo,Vena Antonio,Labate Laura,Giacobbe Daniele R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical)

Reference75 articles.

1. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents;Kadri;Clin Infect Dis,2018

2. Treatment of bloodstream infections due to Gram-negative bacteria with difficult-to-treat resistance;Bassetti;Antibiotics (Basel),2020

3. Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time;Baltas;J Antimicrob Chemother,2021

4. Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: a multicenter nationwide clinical experience (CEFTABUSE II Study);Bassetti;Open Forum Infect Dis,2020

5. Multidrug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study;Zilberberg;Crit Care,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice;European Journal of Clinical Microbiology & Infectious Diseases;2024-03-08

2. An overview of gram-negative bacteria with difficult-to-treat resistance: definition, prevalence, and treatment options;Expert Review of Anti-infective Therapy;2023-10-09

3. State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms;Clinical Infectious Diseases;2023-09-22

4. Effectors of the Type VI Secretion System Have the Potential to Be Modified into Antimicrobial Peptides;Microbiology Spectrum;2023-08-17